Background Prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV)
involves neonatal immunoprophylaxis, with a birth dose of hepatitis B vaccine and immune …

Background HBeAg presence in childbearing-age women is a major determinant of
perinatal hepatitis B virus (HBV) transmission. The risk of developing chronic HBV infection …

Background Preterm birth is the leading cause of child death in children younger than 5
years. Large cohort studies in developed countries have shown that maternal hepatitis B …

Hepatitis B virus (HBV) infection is the commonest cause of chronic hepatitis, with an
estimated global prevalence of 3.5%, and which leads to significant morbidity and mortality …

Despite immunoprophylaxis, hepatitis B virus (HBV) transmission in highly viremic mothers
remains a global health issue. Using quantitative maternal surface antigen (HBsAg) to …

Background. Hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) positive
mother has up to 90% likelihood of mother‐to‐child transmission (MTCT) of hepatitis B virus …

Summary Background In sub-Saharan Africa, administration of hepatitis B virus (HBV) birth-
dose vaccines remains suboptimal. Evidence is scarce on whether African countries should …

BACKGROUND & AIMS: Despite immunoprophylaxis, mother to child transmission (MTCT)
of hepatitis B virus (HBV) still occurs in infants born to hepatitis B surface antigen (HBsAg) …

Background Hepatitis is a viral infection of the liver. It is mainly transmitted between people
through contact with infected blood, frequently from mother to baby in‐utero. Hepatitis B …

BACKGROUND & AIMS: Immunoprophylaxis reduces but does not completely eradicate
hepatitis B virus (HBV) transmission. This prospective study aims at assessing the rate and …